These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32974558)

  • 1. Middle East respiratory coronavirus (MERS-CoV) spike (S) protein vesicular stomatitis virus pseudoparticle neutralization assays offer a reliable alternative to the conventional neutralization assay in human seroepidemiological studies.
    Lester S; Harcourt J; Whitt M; Al-Abdely HM; Midgley CM; Alkhamis AM; Aziz Jokhdar HA; Assiri AM; Tamin A; Thornburg N
    Access Microbiol; 2019; 1(9):e000057. PubMed ID: 32974558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai.
    Lau SKP; Li KSM; Luk HKH; He Z; Teng JLL; Yuen KY; Wernery U; Woo PCY
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31969478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein.
    Fukuma A; Tani H; Taniguchi S; Shimojima M; Saijo M; Fukushi S
    Arch Virol; 2015 Sep; 160(9):2293-300. PubMed ID: 26138557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay.
    Almahboub SA; Algaissi A; Alfaleh MA; ElAssouli MZ; Hashem AM
    Front Microbiol; 2020; 11():2020. PubMed ID: 33013745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA.
    Fukushi S; Fukuma A; Kurosu T; Watanabe S; Shimojima M; Shirato K; Iwata-Yoshikawa N; Nagata N; Ohnishi K; Ato M; Melaku SK; Sentsui H; Saijo M
    J Virol Methods; 2018 Jan; 251():22-29. PubMed ID: 28993122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC.
    Shirato K; Melaku SK; Kawachi K; Nao N; Iwata-Yoshikawa N; Kawase M; Kamitani W; Matsuyama S; Tessema TS; Sentsui H
    Front Microbiol; 2019; 10():1326. PubMed ID: 31275264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV.
    Zhao G; Du L; Ma C; Li Y; Li L; Poon VK; Wang L; Yu F; Zheng BJ; Jiang S; Zhou Y
    Virol J; 2013 Aug; 10():266. PubMed ID: 23978242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia.
    Teramichi T; Fukushi S; Hachiya Y; Melaku SK; Oguma K; Sentsui H
    J Vet Med Sci; 2019 Dec; 81(12):1887-1891. PubMed ID: 31685722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
    Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay.
    Algaissi A; Hashem AM
    Methods Mol Biol; 2020; 2099():107-116. PubMed ID: 31883091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of different indirect ELISAs for MERS-CoV serological testing.
    Hashem AM; Al-Amri SS; Al-Subhi TL; Siddiq LA; Hassan AM; Alawi MM; Alhabbab RY; Hindawi SI; Mohammed OB; Amor NS; Alagaili AN; Mirza AA; Azhar EI
    J Immunol Methods; 2019 Mar; 466():41-46. PubMed ID: 30659836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia.
    Alshukairi AN; Zheng J; Zhao J; Nehdi A; Baharoon SA; Layqah L; Bokhari A; Al Johani SM; Samman N; Boudjelal M; Ten Eyck P; Al-Mozaini MA; Zhao J; Perlman S; Alagaili AN
    mBio; 2018 Oct; 9(5):. PubMed ID: 30377284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013.
    Perera RA; Wang P; Gomaa MR; El-Shesheny R; Kandeil A; Bagato O; Siu LY; Shehata MM; Kayed AS; Moatasim Y; Li M; Poon LL; Guan Y; Webby RJ; Ali MA; Peiris JS; Kayali G
    Euro Surveill; 2013 Sep; 18(36):pii=20574. PubMed ID: 24079378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of MERS-CoV Pseudotyped Viral Particles for the Evaluation of Neutralizing Antibodies in Mammalian Sera.
    Almasaud A; Alharbi NK; Hashem AM
    Methods Mol Biol; 2020; 2099():117-126. PubMed ID: 31883092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
    Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
    mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
    Zettl F; Meister TL; Vollmer T; Fischer B; Steinmann J; Krawczyk A; V'kovski P; Todt D; Steinmann E; Pfaender S; Zimmer G
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32679691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.